CORT · Categories · Downgrades
CORT - Analyst downgrades
Corcept Therapeutics Incorporated (CORT) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for CORT
- Corcept Therapeutics downgraded by Wolfe Research with a new price targetWolfe Research downgraded Corcept Therapeutics from Peer Perform to Underperform and set a new price target of $30.00
- Corcept Therapeutics downgraded by Jefferies with a new price targetJefferies downgraded Corcept Therapeutics from Buy to Hold and set a new price target of $22.00 from $35.00 previously
- Corcept Therapeutics downgraded by Truist with a new price targetTruist downgraded Corcept Therapeutics from Buy to Hold and set a new price target of $30.00